Isofol Medical AB (ISOFOL) — Cash Flow-to-Debt Ratio
Latest as of September 2025:
-0.50x
Isofol Medical AB (ISOFOL) has a Cash Flow-to-Debt Ratio of -0.50x as of September 2025, meaning its operating cash flow of Skr-10.78 Million could theoretically repay -1% of its total liabilities (Skr21.51 Million) in one year. See ISOFOL FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
-0.50x
Operating CF / Total Liabilities
Operating Cash Flow
Skr-10.78 Million
SEK
Total Liabilities
Skr21.51 Million
SEK
Data as of
Sep 2025
Most recent filing
Isofol Medical AB Cash Flow-to-Debt Ratio (2015–2025)
Historical debt coverage capacity for Isofol Medical AB across 11 annual periods. For the full cash flow conversion analysis, see Isofol Medical AB cash flow conversion.
Annual Cash Flow-to-Debt Ratio for Isofol Medical AB (2015–2025)
Year-by-year debt coverage analysis for Isofol Medical AB.
| Year | CF-to-Debt Ratio | Operating CF (SEK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -2.41x | Skr-51.94 Million | Skr21.52 Million | ▼ -17.6% |
| 2024 | -2.05x | Skr-41.99 Million | Skr20.47 Million | ▲ +25.2% |
| 2023 | -2.74x | Skr-52.54 Million | Skr19.16 Million | ▲ +21.1% |
| 2022 | -3.47x | Skr-190.97 Million | Skr54.99 Million | ▼ -53.2% |
| 2021 | -2.27x | Skr-188.43 Million | Skr83.13 Million | ▼ -15.4% |
| 2020 | -1.96x | Skr-160.27 Million | Skr81.56 Million | ▲ +44.5% |
| 2019 | -3.54x | Skr-147.21 Million | Skr41.56 Million | ▲ +9.8% |
| 2018 | -3.93x | Skr-92.46 Million | Skr23.54 Million | ▼ -15.7% |
| 2017 | -3.40x | Skr-61.94 Million | Skr18.24 Million | ▼ -0.2% |
| 2016 | -3.39x | Skr-56.90 Million | Skr16.79 Million | ▲ +22.1% |
| 2015 | -4.35x | Skr-36.77 Million | Skr8.46 Million | — |
Cash Flow-to-Debt Ratio = Operating Cash Flow / Total Liabilities. Higher is better for debt service capacity.